BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 52 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $9,000 | 0.0% | 9,000 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $9,000 | 0.0% | 9,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $9,000 | 0.0% | 9,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $9,000 | 0.0% | 9,000 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $9,000 | 0.0% | 9,000 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $9,000 | 0.0% | 9,000 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $9,000 | 0.0% | 9,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $9,000 | – | 9,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERBACK ASSET MANAGEMENT LLC | 36,000,000 | $36,583,000 | 5.85% |
Man Investments (CH) AG | 3,200,000 | $3,250,000 | 2.78% |
Verde Servicos Internacionais S.A. | 11,000,000 | $11,165,000 | 2.06% |
Jabre Capital Partners S.A. | 10,000,000 | $10,156,000 | 1.97% |
LINDEN ADVISORS LP | 38,500,000 | $39,095,000 | 1.39% |
Opera Trading Capital | 9,900,000 | $9,925,000 | 1.35% |
Sonora Investment Management, LLC | 4,950,000 | $5,029,596,000 | 0.87% |
CQS Cayman LP | 10,000,000 | $10,165,000 | 0.68% |
Polar Asset Management Partners Inc. | 25,000,000 | $25,384,000 | 0.51% |
ADVENT CAPITAL MANAGEMENT /DE/ | 26,000,000 | $26,383,000 | 0.50% |